Cronos Group Inc. (NASDAQ:CRON - Get Free Report) shares were down 3.1% during mid-day trading on Monday . The company traded as low as $1.70 and last traded at $1.70. Approximately 122,512 shares traded hands during trading, a decline of 92% from the average daily volume of 1,469,861 shares. The stock had previously closed at $1.75.
Cronos Group Stock Performance
The company has a market capitalization of $682.17 million, a price-to-earnings ratio of -13.62, a P/E/G ratio of 1.74 and a beta of 1.02. The firm has a 50-day simple moving average of $1.85 and a two-hundred day simple moving average of $1.98.
Institutional Investors Weigh In On Cronos Group
Several hedge funds have recently bought and sold shares of CRON. Thompson Davis & CO. Inc. purchased a new stake in Cronos Group during the fourth quarter worth $29,000. Tower Research Capital LLC TRC grew its position in shares of Cronos Group by 140.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company's stock valued at $28,000 after acquiring an additional 8,019 shares during the period. SBI Securities Co. Ltd. purchased a new position in shares of Cronos Group in the 4th quarter valued at about $30,000. Jones Financial Companies Lllp raised its holdings in Cronos Group by 64.5% in the 4th quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock worth $34,000 after purchasing an additional 6,520 shares during the period. Finally, Zacks Investment Management purchased a new position in Cronos Group during the fourth quarter worth approximately $38,000. Hedge funds and other institutional investors own 8.71% of the company's stock.
About Cronos Group
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Articles
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
